ovarian-cancer

Documents about ovarian-cancer

• Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients#850630ClinicalTrials.gov
• Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India#911981ClinicalTrials.gov
• Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer#874491ClinicalTrials.gov
• Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer#897404ClinicalTrials.gov
• Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy#845052ClinicalTrials.gov
• Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer#896683ClinicalTrials.gov
• To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers#857120ClinicalTrials.gov
• Quality of Life in Survivors of Gynecologic Cancer#834923ClinicalTrials.gov
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer or Primary Peritoneal Cancer#862299ClinicalTrials.gov
• Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer#876953ClinicalTrials.gov
• Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer#866622ClinicalTrials.gov
• Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer#852049ClinicalTrials.gov
• Letrozole in Patients With Ovarian Tumors#854913ClinicalTrials.gov
• Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer#148623ClinicalTrials.gov
• Safety of Active Immunotherapy in Subjects With Ovarian Cancer#162476ClinicalTrials.gov
• p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer#234483ClinicalTrials.gov
• Plasmodium Immunotherapy for Advanced Ovarian Cancer#633729ClinicalTrials.gov
• The Immune Landscape of Epithelial Ovarian Cancer#812598ClinicalTrials.gov
• Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer#826087ClinicalTrials.gov
• Patients Derived Organoids in Ovarian Cancer#833428ClinicalTrials.gov
• SGI-110 in Combination With Carboplatin in Ovarian Cancer#839915ClinicalTrials.gov
• A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer#883432ClinicalTrials.gov
• Trial on Radical Upfront Surgery in Advanced Ovarian Cancer#886045ClinicalTrials.gov
• WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer#886510ClinicalTrials.gov
• Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer#121452ClinicalTrials.gov
• Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer#884209ClinicalTrials.gov
• PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer#825060ClinicalTrials.gov
• Pathway to Diagnosis of Ovarian Cancer#851317ClinicalTrials.gov
• Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer#913140ClinicalTrials.gov
• Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer#900573ClinicalTrials.gov
• Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries#851408ClinicalTrials.gov
• Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.#916405ClinicalTrials.gov
• Elizabeth Registry for Low Grade Ovarian Cancer#866999ClinicalTrials.gov
• A Study LY2228820 for Recurrent Ovarian Cancer#884689ClinicalTrials.gov
• OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission#356523ClinicalTrials.gov
• Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer#860678ClinicalTrials.gov
• Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer#914255ClinicalTrials.gov
• Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer#201792ClinicalTrials.gov
• Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer#356469ClinicalTrials.gov
• Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment#432889ClinicalTrials.gov
• Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients#640576ClinicalTrials.gov
• Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer#891801ClinicalTrials.gov
• Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer#307438ClinicalTrials.gov
• Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)#861291ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer#398186ClinicalTrials.gov
• Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian Cancer#463763ClinicalTrials.gov
• Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer#812675ClinicalTrials.gov
• QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy#394767ClinicalTrials.gov
• Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients#812241ClinicalTrials.gov
• Phase I/II Study of Pazopanib and Cyclophosphamide in Patients With Platinum-resistant Recurrent Ovarian Cancer#916069ClinicalTrials.gov